Urinary Tract Infections clinical trials

Explore recruiting urinary tract infections clinical trials.

Recruiting urinary tract infections studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Urinary Tract Infections trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Intravenous Fosfomycin in hospitalized patients with complicated urinary tract infections due to Third-generation cephalosporinresistant Enterobacterales

Italy

Therapeutic use (Phase IV) EU CTIS Study details

Personalized antibiotic TREATment for febrile Urinary Tract Infections in children (TREAT-UTI study): multicenter randomized controlled trial

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase 1, Open-Label, single arm (Non-comparator) Study to Evaluate the Pharmacokinetics and Safety of a Single Dose of Oral Gepotidacin in Addition to Antibacterial Standard of Care in Pediatric Participants from 2 to less than 12 years of age with a Suspected or Confirmed Bacterial Infection or Receiving Prophylaxis with Antibiotics

Spain, Poland

Human Pharmacology (Phase I)- Other EU CTIS Study details

RETRAIN - Multicentre randomised double-blind superiority trial with a roll-over phase to evaluate the efficacy of OM-89 vs placebo in reducing antibiotic consumption associated with the treatment of urinary tract infections in patients with a neurological bladder.

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Evidence based empirical antibiotic treatment for urinary tract infections requiring hospitalisation - TRI-AB trial

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

A randomized controlled non-inferiority trial comparing 7 versus 14 days of ciprofloxacin for male urinary tract infections with systemic involvement.

Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

Urinary Tract Infections trials by city

Urinary Tract Infections in Toronto Urinary Tract Infections in Vancouver Urinary Tract Infections in Montreal Urinary Tract Infections in Calgary Urinary Tract Infections in Edmonton Urinary Tract Infections in Ottawa Urinary Tract Infections in Winnipeg Urinary Tract Infections in Quebec City Urinary Tract Infections in Hamilton Urinary Tract Infections in Kitchener Urinary Tract Infections in London Urinary Tract Infections in Halifax Urinary Tract Infections in New York Urinary Tract Infections in Los Angeles Urinary Tract Infections in Chicago Urinary Tract Infections in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease